Cellular Reprogramming Allows Generation of Autologous Hematopoietic Progenitors From AML Patients That Are Devoid of Patient-Specific Genomic Aberrations

Current treatments that use hematopoietic progenitor cell (HPC) transplantation in acute myeloid leukemia (AML) patients substantially reduce the risk of relapse, but are limited by the availability of immune compatible healthy HPCs. Although cellular reprogramming has the potential to provide a nov...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Stem Cells
Main Authors: Salci, Kyle R, Lee, Jong-Hee, Laronde, Sarah, Dingwall, Steve, Kushwah, Rahul, Fiebig-Comyn, Aline, Leber, Brian, Foley, Ronan, Dal Cin, Arianna, Bhatia, Mickie
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley & Sons, Ltd 2015
Assuntos:
Regenerative Medicine
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4691325/
https://ncbi.nlm.nih.gov/pubmed/25764124
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/stem.1994
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares